Septerna, Inc.

US$48.85As of Sun 8 Nov 2026, 12:00 UTC
NASDAQ:SEPNHealthcare
Country USA
PE (Fwd) •••
TSR 2Y CAGR 45.56%
Div yield —
ROE (6.34%)
Biotechnology
Beta (5Y) 2.20
PE TTM —
TSR TTM 137.14%
Mkt cap US$2.280B
ROIC (123.05%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
$63
29.97%
(33.50%)
Hold 1|10|9|6|5
4Q25
1Q26
2Q26
3Q26
Earnings per share$
0.54
0.52
0.57
0.62
17.83%
3.24%
14.72%
27.48%
Revenue$M
92.78
95.64
100.6
105.6
(4.36%)
(1.53%)
3.94%
10.93%
Peers (US$2.280B)
Cap (US$)
PE
2.208B
—
Capital
TTM
5Y
10Y
Leveragex
0.322
0.300
0.278
EBIT/Intx
0.748
0.088
0.089
Own earn%
(92.08)
207.49
167.48
Sh yield%
38.38
9.75
11.83
Owners
Insiders/Inst%
3.79
83.99
Short interest%
4.36
SBC / revenue%
3.52
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
18
Op margin range%
11–19
$1 testx
—
Incr. ROIC%
1